269 related articles for article (PubMed ID: 7727461)
1. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
[TBL] [Abstract][Full Text] [Related]
2. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
4. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
5. Effects of early steroid withdrawal after heart transplantation.
Rosenbaum DH; Adams BC; Mitchell JD; Jessen ME; Paul MC; Kaiser PA; Pappas PA; Meyer DM; Wait MA; Drazner MH; Yancy CW; Ring WS; DiMaio JM
Ann Thorac Surg; 2006 Aug; 82(2):637-44; discussion 644. PubMed ID: 16863778
[TBL] [Abstract][Full Text] [Related]
6. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
10. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
[TBL] [Abstract][Full Text] [Related]
11. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
[TBL] [Abstract][Full Text] [Related]
12. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
[TBL] [Abstract][Full Text] [Related]
13. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
[TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
[TBL] [Abstract][Full Text] [Related]
15. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression.
Canter CE; Moorhead S; Saffitz JE; Huddleston CB; Spray TL
J Heart Lung Transplant; 1994; 13(1 Pt 1):74-9; discussion 79-80. PubMed ID: 8167131
[TBL] [Abstract][Full Text] [Related]
16. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
[TBL] [Abstract][Full Text] [Related]
17. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
Olivari MT; Homans DC; Wilson RF; Kubo SH; Ring WS
Circulation; 1989 Nov; 80(5 Pt 2):III111-5. PubMed ID: 2805289
[TBL] [Abstract][Full Text] [Related]
20. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
